Clinical Trials Browser

Interventional × Melanoma, Cutaneous Malignant × 90 days × Clear all

NCT06743126 2026-05-29

SUPRAME

Phase 3 Recruiting

Melanoma, Cutaneous Malignant

NCT04620603 2026-05-05

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Phase 1 Active not recruiting

DermatologicGenitourinary

Melanoma, Cutaneous Malignant, Carcinoma, Renal Cell